Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease
Top Cited Papers
- 1 April 2003
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 114 (5) , 359-364
- https://doi.org/10.1016/s0002-9343(03)00010-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Mechanisms modifying atherosclerotic disease — from lipids to vascular biologyAtherosclerosis, 1999
- Cilostazol Has Beneficial Effects in Treatment of Intermittent ClaudicationCirculation, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical eventsJournal of the American College of Cardiology, 1995
- Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery diseaseThe American Journal of Cardiology, 1995
- Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1995
- Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)The Lancet, 1994
- Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries.Circulation Research, 1988
- The prevalence of peripheral arterial disease in a defined population.Circulation, 1985